Skip to search formSkip to main contentSkip to account menu

cericlamine

Known as: 2-(3,4-dichlorobenzyl)-2-dimethylamino-1-propanol 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

JO 1017

Broader (1)

Propanolamines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Reduced inhibitory potency of serotonin reuptake blockers on central serotoninergic neurons in rats selectively deprived of rapid eye movement sleep
Highly Cited
1994
Highly Cited
1994
Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
Biochemical and electrophysiological approaches were used to assess the possible changes in 5-hydroxytryptamine (serotonin) 5… 
Review
1994
Review
1994
[Antidepressives of the 3rd, 4th and 5th generation].
Antidepressants are classified into five generations. Preparations of the first generation affect various neurotransmitter… 
1992
1992
Discriminative stimulus effects of alprazolam and diazepam: generalization to benzodiazepines, antidepressants and buspirone
Rats in one group were trained to discriminate alprazolam (1.0 mg/kg, i. p.) and in another group diazepam (3.0 mg/kg, i. p… 
1992
1992
A MULTICENTRE DOUBLE‐BLIND, PLACEBO‐CONTROLLED DOSE‐FINDING STUDY WITH CERICLAMINE IN MAJOR DEPRESSION.
1990
1990
Biochemical and pharmacological evaluation of the novel antidepressant and serotonin uptake inhibitor 2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol hydrochloride.
2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol, hydrochloride (JO 1017) is a novel antidepressant drug. Its biochemical and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)